The UKHSA’s Purchase of Covid Vaccines
Distinctly dynamic
In our efforts to keep tabs on what the UK Scare Agency is up to with our cash,
we came across this contract notice.
The notice informs us that the UKHSA has established preferential channels to purchase COVID-19 vaccines valued between £1 and £1,000,000,000 between 2024 and 2028.
For the time being, we will leave aside the assessment of the effects of said vaccines, which we have shown to have initially been a political affair (and we suspect continues to be so); some aspects of the announcement interested us.
The eye-watering sum set aside for the purchase of vaccines with an uncertain effectiveness and harms profile is one.
And then the following:
The Authority is establishing a Dynamic Purchasing System (DPS) for product(s) indicated for protection from COVID-19 for future immunisation campaigns. The duration of the DPS will be for 4 years (2024-2028).
UKHSA anticipates a requirement over the period 2024 to 2028 for the supply of product(s) indicated for protection from COVID-19. The a…
